Results - Announcements
Rossari Biotech Ltd share price ticked higher by 4.20% to Rs 454.95 after the company's net profit registered a growth of 10.85% to Rs 38.91 crore, while revenue from operations slightly gained 0.05% to Rs 697.56 crore in Q3FY26 over Q2FY26.
The market capitalization of Specialty Chemicals industry group stocks on BSE stood at Rs 5.55 lakh crore, rallying 15.80%. It has softened by 0.67% over last one week and eased lower by 0.46% in last one month while the market capitalization of Rossari Biotech Ltd has improved by 6.72% and 11.17% in the same period respectively.
Profit before tax (PBT) of Rossari Biotech Ltd stood at Rs 49.27 crore in Q3 FY26, slipping 0.81% year-on-year, and rising 3.36% quarter-on-quarter. EBITDA came in at Rs 86 crore, jumping 22.84% YoY and heading higher 11.54% sequentially.
Total expenses eased by 0.24% to Rs 640.68 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 475.64 crore, easing 7.59% YoY, while employee benefits expense was at Rs 43.62 crore, dipping slightly 0.95% YoY.
For the TTM ended FY26, revenue from operations rose 15.19% to Rs 2396.37 crore, while net profit saw a marginal increase of 9.41% to Rs 149.21 crore, compared to previous TTM. EBITDA surged by 27212% to Rs 263.52 crore, and PBT saw a minor gain of 9.36% to Rs 202.52 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 65.07 crore in FY26, as against Rs 137.44 crore in FY25.
Rossari Biotech Ltd tumbled by 32.40% in last one year, underperforming the benchmark BSE Sensex which has reduced by 10.47% during the same period.